protocolSection identificationModule nctId: NCT06362265, orgStudyIdInfo id: 18437, secondaryIdInfos id: I8H-MC-BDDB, type: OTHER, domain: Eli Lilly and Company, briefTitle: A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2026-11, completionDateStruct date: 2026-11, studyFirstPostDateStruct date: 2024-04-12, lastUpdatePostDateStruct date: 2024-04-19, sponsorCollaboratorsModule leadSponsor name: Eli Lilly and Company, class: INDUSTRY, descriptionModule briefSummary: The main purpose of this study is to evaluate how much of LY3209590 gets into the blood stream after a single dose and how long it takes the body to remove it in pediatric participants with Type 2 Diabetes Mellitus (T2DM). The study will last for approximately 100 days., conditionsModule conditions: Type 2 Diabetes Mellitus, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: NON_RANDOMIZED, interventionModel: SINGLE_GROUP, primaryPurpose: BASIC_SCIENCE, maskingInfo masking: NONE, enrollmentInfo count: 22, type: ESTIMATED, armsInterventionsModule interventions name: LY3209590, outcomesModule primaryOutcomes measure: Pharmacokinetics (PK): Area Under the Plasma Concentration Versus Time Curve (AUC) of LY3209590, primaryOutcomes measure: PK: Maximum Observed Plasma Concentration (Cmax) of LY3209590, secondaryOutcomes measure: Change from Baseline in Fasting Glucose, eligibilityModule sex: ALL, minimumAge: 10 Years, maximumAge: 17 Years, stdAges: CHILD, contactsLocationsModule locations facility: Honor Health Research Institute, city: Scottsdale, state: Arizona, zip: 85258, country: United States, geoPoint lat: 33.50921, lon: -111.89903, locations facility: Children's Hospital Los Angeles, city: Los Angeles, state: California, zip: 90027, country: United States, geoPoint lat: 34.05223, lon: -118.24368, locations facility: Children's Healthcare of Atlanta - Center for Advanced Pediatrics, city: Atlanta, state: Georgia, zip: 30329, country: United States, geoPoint lat: 33.749, lon: -84.38798, locations facility: University of Louisville, Norton Children's Research Institute, city: Louisville, state: Kentucky, zip: 40202, country: United States, geoPoint lat: 38.25424, lon: -85.75941, locations facility: Johns Hopkins University School of Medicine, city: Baltimore, state: Maryland, zip: 21287, country: United States, geoPoint lat: 39.29038, lon: -76.61219, locations facility: Joslin Diabetes Center, city: Boston, state: Massachusetts, zip: 02215, country: United States, geoPoint lat: 42.35843, lon: -71.05977, locations facility: UBMD Pediatrics, city: Buffalo, state: New York, zip: 14203, country: United States, geoPoint lat: 42.88645, lon: -78.87837, locations facility: NYU Langone, city: New York, state: New York, zip: 10016, country: United States, geoPoint lat: 40.71427, lon: -74.00597, locations facility: Cincinnati Children's Hospital Medical Center, city: Cincinnati, state: Ohio, zip: 45229, country: United States, geoPoint lat: 39.12713, lon: -84.51435, locations facility: Children's Hospital of Philadelphia, city: Philadelphia, state: Pennsylvania, zip: 19104, country: United States, geoPoint lat: 39.95233, lon: -75.16379, hasResults: False